Cyamemazine

DB09000ExperimentalSmall molecule

Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class used primarily in the treatment of schizophrenia and psychosis-associated anxiety. Cyamemazine actually behaves like an... Cyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).

Chemical structure of Cyamemazine
Formula / weight
C19H21N3S · 323.455 g/mol (avg)

Resolves to

Compound
UNIIA2JGV5CNU4CAS3546-03-0ChEMBLCHEMBL2104153ChEBI135379PubChem62865KEGGD07307
Clinical / RWD
RxNorm21877ATCN05AA06
Structure
InChIKeySLFGIOIONGJGRT-UHFFFAOYSA-NSMILESCC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N
Targets
P28335HTR2CP34969HTR7P08908HTR1AP28223HTR2A

What you can answer from here — as of January 29, 2025

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
834Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cyamemazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In